A Novel Antiviral Target Structure Involved in the RNA Binding, Dimerization, and Nuclear Export Functions of the Influenza A Virus Nucleoprotein.
Developing antiviral therapies for influenza A virus (IAV) infection is an ongoing process because of the rapid rate of antigenic mutation and the emergence of drug-resistant viruses. The ideal strategy is to develop drugs that target well-conserved, functionally restricted, and unique surface struc...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-07-01
|
Series: | PLoS Pathogens |
Online Access: | http://europepmc.org/articles/PMC4519322?pdf=render |
id |
doaj-bd558cf880da4eb8a4a1eb2d8ec82d66 |
---|---|
record_format |
Article |
spelling |
doaj-bd558cf880da4eb8a4a1eb2d8ec82d662020-11-24T22:10:38ZengPublic Library of Science (PLoS)PLoS Pathogens1553-73661553-73742015-07-01117e100506210.1371/journal.ppat.1005062A Novel Antiviral Target Structure Involved in the RNA Binding, Dimerization, and Nuclear Export Functions of the Influenza A Virus Nucleoprotein.Michinori KakisakaYutaka SasakiKazunori YamadaYasumitsu KondohHirokazu HikonoHiroyuki OsadaKentaro TomiiTakehiko SaitoYoko AidaDeveloping antiviral therapies for influenza A virus (IAV) infection is an ongoing process because of the rapid rate of antigenic mutation and the emergence of drug-resistant viruses. The ideal strategy is to develop drugs that target well-conserved, functionally restricted, and unique surface structures without affecting host cell function. We recently identified the antiviral compound, RK424, by screening a library of 50,000 compounds using cell-based infection assays. RK424 showed potent antiviral activity against many different subtypes of IAV in vitro and partially protected mice from a lethal dose of A/WSN/1933 (H1N1) virus in vivo. Here, we show that RK424 inhibits viral ribonucleoprotein complex (vRNP) activity, causing the viral nucleoprotein (NP) to accumulate in the cell nucleus. In silico docking analysis revealed that RK424 bound to a small pocket in the viral NP. This pocket was surrounded by three functionally important domains: the RNA binding groove, the NP dimer interface, and nuclear export signal (NES) 3, indicating that it may be involved in the RNA binding, oligomerization, and nuclear export functions of NP. The accuracy of this binding model was confirmed in a NP-RK424 binding assay incorporating photo-cross-linked RK424 affinity beads and in a plaque assay evaluating the structure-activity relationship of RK424. Surface plasmon resonance (SPR) and pull-down assays showed that RK424 inhibited both the NP-RNA and NP-NP interactions, whereas size exclusion chromatography showed that RK424 disrupted viral RNA-induced NP oligomerization. In addition, in vitro nuclear export assays confirmed that RK424 inhibited nuclear export of NP. The amino acid residues comprising the NP pocket play a crucial role in viral replication and are highly conserved in more than 7,000 NP sequences from avian, human, and swine influenza viruses. Furthermore, we found that the NP pocket has a surface structure different from that of the pocket in host molecules. Taken together, these results describe a promising new approach to developing influenza virus drugs that target a novel pocket structure within NP.http://europepmc.org/articles/PMC4519322?pdf=render |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Michinori Kakisaka Yutaka Sasaki Kazunori Yamada Yasumitsu Kondoh Hirokazu Hikono Hiroyuki Osada Kentaro Tomii Takehiko Saito Yoko Aida |
spellingShingle |
Michinori Kakisaka Yutaka Sasaki Kazunori Yamada Yasumitsu Kondoh Hirokazu Hikono Hiroyuki Osada Kentaro Tomii Takehiko Saito Yoko Aida A Novel Antiviral Target Structure Involved in the RNA Binding, Dimerization, and Nuclear Export Functions of the Influenza A Virus Nucleoprotein. PLoS Pathogens |
author_facet |
Michinori Kakisaka Yutaka Sasaki Kazunori Yamada Yasumitsu Kondoh Hirokazu Hikono Hiroyuki Osada Kentaro Tomii Takehiko Saito Yoko Aida |
author_sort |
Michinori Kakisaka |
title |
A Novel Antiviral Target Structure Involved in the RNA Binding, Dimerization, and Nuclear Export Functions of the Influenza A Virus Nucleoprotein. |
title_short |
A Novel Antiviral Target Structure Involved in the RNA Binding, Dimerization, and Nuclear Export Functions of the Influenza A Virus Nucleoprotein. |
title_full |
A Novel Antiviral Target Structure Involved in the RNA Binding, Dimerization, and Nuclear Export Functions of the Influenza A Virus Nucleoprotein. |
title_fullStr |
A Novel Antiviral Target Structure Involved in the RNA Binding, Dimerization, and Nuclear Export Functions of the Influenza A Virus Nucleoprotein. |
title_full_unstemmed |
A Novel Antiviral Target Structure Involved in the RNA Binding, Dimerization, and Nuclear Export Functions of the Influenza A Virus Nucleoprotein. |
title_sort |
novel antiviral target structure involved in the rna binding, dimerization, and nuclear export functions of the influenza a virus nucleoprotein. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS Pathogens |
issn |
1553-7366 1553-7374 |
publishDate |
2015-07-01 |
description |
Developing antiviral therapies for influenza A virus (IAV) infection is an ongoing process because of the rapid rate of antigenic mutation and the emergence of drug-resistant viruses. The ideal strategy is to develop drugs that target well-conserved, functionally restricted, and unique surface structures without affecting host cell function. We recently identified the antiviral compound, RK424, by screening a library of 50,000 compounds using cell-based infection assays. RK424 showed potent antiviral activity against many different subtypes of IAV in vitro and partially protected mice from a lethal dose of A/WSN/1933 (H1N1) virus in vivo. Here, we show that RK424 inhibits viral ribonucleoprotein complex (vRNP) activity, causing the viral nucleoprotein (NP) to accumulate in the cell nucleus. In silico docking analysis revealed that RK424 bound to a small pocket in the viral NP. This pocket was surrounded by three functionally important domains: the RNA binding groove, the NP dimer interface, and nuclear export signal (NES) 3, indicating that it may be involved in the RNA binding, oligomerization, and nuclear export functions of NP. The accuracy of this binding model was confirmed in a NP-RK424 binding assay incorporating photo-cross-linked RK424 affinity beads and in a plaque assay evaluating the structure-activity relationship of RK424. Surface plasmon resonance (SPR) and pull-down assays showed that RK424 inhibited both the NP-RNA and NP-NP interactions, whereas size exclusion chromatography showed that RK424 disrupted viral RNA-induced NP oligomerization. In addition, in vitro nuclear export assays confirmed that RK424 inhibited nuclear export of NP. The amino acid residues comprising the NP pocket play a crucial role in viral replication and are highly conserved in more than 7,000 NP sequences from avian, human, and swine influenza viruses. Furthermore, we found that the NP pocket has a surface structure different from that of the pocket in host molecules. Taken together, these results describe a promising new approach to developing influenza virus drugs that target a novel pocket structure within NP. |
url |
http://europepmc.org/articles/PMC4519322?pdf=render |
work_keys_str_mv |
AT michinorikakisaka anovelantiviraltargetstructureinvolvedinthernabindingdimerizationandnuclearexportfunctionsoftheinfluenzaavirusnucleoprotein AT yutakasasaki anovelantiviraltargetstructureinvolvedinthernabindingdimerizationandnuclearexportfunctionsoftheinfluenzaavirusnucleoprotein AT kazunoriyamada anovelantiviraltargetstructureinvolvedinthernabindingdimerizationandnuclearexportfunctionsoftheinfluenzaavirusnucleoprotein AT yasumitsukondoh anovelantiviraltargetstructureinvolvedinthernabindingdimerizationandnuclearexportfunctionsoftheinfluenzaavirusnucleoprotein AT hirokazuhikono anovelantiviraltargetstructureinvolvedinthernabindingdimerizationandnuclearexportfunctionsoftheinfluenzaavirusnucleoprotein AT hiroyukiosada anovelantiviraltargetstructureinvolvedinthernabindingdimerizationandnuclearexportfunctionsoftheinfluenzaavirusnucleoprotein AT kentarotomii anovelantiviraltargetstructureinvolvedinthernabindingdimerizationandnuclearexportfunctionsoftheinfluenzaavirusnucleoprotein AT takehikosaito anovelantiviraltargetstructureinvolvedinthernabindingdimerizationandnuclearexportfunctionsoftheinfluenzaavirusnucleoprotein AT yokoaida anovelantiviraltargetstructureinvolvedinthernabindingdimerizationandnuclearexportfunctionsoftheinfluenzaavirusnucleoprotein AT michinorikakisaka novelantiviraltargetstructureinvolvedinthernabindingdimerizationandnuclearexportfunctionsoftheinfluenzaavirusnucleoprotein AT yutakasasaki novelantiviraltargetstructureinvolvedinthernabindingdimerizationandnuclearexportfunctionsoftheinfluenzaavirusnucleoprotein AT kazunoriyamada novelantiviraltargetstructureinvolvedinthernabindingdimerizationandnuclearexportfunctionsoftheinfluenzaavirusnucleoprotein AT yasumitsukondoh novelantiviraltargetstructureinvolvedinthernabindingdimerizationandnuclearexportfunctionsoftheinfluenzaavirusnucleoprotein AT hirokazuhikono novelantiviraltargetstructureinvolvedinthernabindingdimerizationandnuclearexportfunctionsoftheinfluenzaavirusnucleoprotein AT hiroyukiosada novelantiviraltargetstructureinvolvedinthernabindingdimerizationandnuclearexportfunctionsoftheinfluenzaavirusnucleoprotein AT kentarotomii novelantiviraltargetstructureinvolvedinthernabindingdimerizationandnuclearexportfunctionsoftheinfluenzaavirusnucleoprotein AT takehikosaito novelantiviraltargetstructureinvolvedinthernabindingdimerizationandnuclearexportfunctionsoftheinfluenzaavirusnucleoprotein AT yokoaida novelantiviraltargetstructureinvolvedinthernabindingdimerizationandnuclearexportfunctionsoftheinfluenzaavirusnucleoprotein |
_version_ |
1725807352429412352 |